United States securities and exchange commission logo April 1, 2021 Carl W. Hull Chief Executive Officer Maravai LifeSciences Holdings, Inc. 10770 Wateridge Circle Suite 200 San Diego, California 92121 Re: Maravai LifeSciences Holdings, Inc. Draft Registration Statement on Form S-1 Submitted March 25, 2021 CIK No. 0001823239 Dear Mr. Hull: This is to advise you that we do not intend to review your registration statement. We request that you publicly file your registration statement no later than 48 hours prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Abby Adams at (202) 551-6902 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Robert E. Goedert, P.C.